Bellevue Group AG

Q4 2023 13F Detailed Holdings

Location
Kuesnacht, Switzerland
Holdings as of
12/31/2023
Value ($000)
$6,537,470
Num holdings
202
Date filed
2/14/2024
Form type
13F-HR
Prev filing
11/14/2023
Next filing
5/15/2024
Note
Holdings broken out by “other managers” reported in original SEC filing, see here for holdings aggregated across other managers
Sym Issuer Name Cl CUSIP Value ($000) % Shares Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 BB Biotech AG 28-06964
2 Bellevue Asset Management AG 28-16892
3 Bellevue Asset Management (UK) Ltd. 28-20408